Nulet 5 Tablet MD contains Aripiprazole 5mg, an atypical antipsychotic medication primarily indicated for the treatment of schizophrenia, bipolar disorder, and as an adjunctive therapy for major depressive disorder. Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, thereby modulating neurotransmitter activity in the brain to restore chemical balance. This mechanism helps alleviate symptoms such as hallucinations, delusions, mood swings, and depressive episodes. Nulet 5 Tablet MD is typically administered once daily, with dosage adjustments based on clinical response and tolerability. Common side effects may include nausea, dizziness, insomnia, and akathisia, while serious adverse effects can involve extrapyramidal symptoms, neuroleptic malignant syndrome, and metabolic changes. Caution is advised in patients with a history of cardiovascular disease, seizures, or diabetes. Regular monitoring of weight, blood glucose, and lipid profile is recommended during prolonged therapy. Nulet 5 Tablet MD should be used under strict medical supervision, with gradual dose titration to minimize adverse effects. It is contraindicated in patients with known hypersensitivity to Aripiprazole or any formulation components. Patient adherence and follow-up are essential to optimize therapeutic outcomes and ensure safety.